Skip to main content
NCBI home page
BMC Chemistry logoLink to BMC Chemistry
. 2019 Mar 28;13(1):40. doi: 10.1186/s13065-019-0545-3

A facile and efficient synthesis of 1,8-dioxodecahydroacridines derivatives catalyzed by cobalt–alanine metal complex under aqueous ethanol media

M Mujahid Alam 1,✉, Ahmed T Mubarak 1, Mohammed A Assiri 1, S Merajuddin Ahmed 1, Ahmed M Fouda 1
PMCID: PMC6661749  PMID: 31384788

Abstract

A facile and convenient method for the synthesis of acridines and its derivatives was developed through one-pot, three-component condensation reaction of aromatic aldehydes, 5,5-dimethyl-1,3-cyclohexanedione, aryl amines or ammonium acetates in the presence of a catalytic amount of cobalt–alanine metal complex using aqueous ethanol as a reaction medium is reported. The present described novel methodology offers several advantages over the traditional methods reported in the literature, such as mild reaction conditions, inexpensive catalyst, short reaction times, excellent yields of products, simplicity and easy workup are the advantages of this procedure.

Keywords: Cobalt–alanine metal complex; Multi component reaction (MCR); Dimedone; Ammonium acetate; 1,8-Dioxodecahydroacridine; One-pot synthesis

Introduction

Multi-component reactions (MCRs) have been paid much attention by synthetic organic chemists worldwide due to the effectiveness of multiple component reactions at building functionalized, novel drug discovery procedures and allow the fast, automated and high-throughput generation of organic compounds [1]. Thus we believe that discovering and developing new and novel bond formation of C–N, C–O and C–S bonds by MCRs is usual in numerous heterocyclic compounds is an important pursuit in pharmaceutical, biological and material science [2]. Consequently, the development of new multicomponent reactions towards biomedical and industrial scaffolds is inevitable at the present time. Therefore, in the last decade research in academia and industry has increasingly emphasized on the use of MCRs [3–11].

Acridine-1,8-dione and acridine derivatives are well known polyfunctionalized 1,4-dihydropyridines (DHPs) [12]. These derivatives of DHPs have an important ring skeleton and reported wide range of pharmaceutical and biological properties, including antitumor [13], antitubercular [14], antimalaria [15], antibacterial [16], antihypertensive [17], fungicidal [18], anticancer [19], anti-inflammatory [20] and diabetes [21]. These derivatives are also commercially used as calcium channel blockers [22–24]. Further, these compounds are also useful for the treatment of angina pectoris [25], hypertension [26–28] and Alzheimer’ disease [29]. Few of these compounds are used as effective drug for the treatment of congestive heart failure [30]. 1,4-Dihydropyridine derivatives are used in numerous bioactive compounds [31–33]. 1,8-Dioxo-decahydroacridines derivatives are using as dyes [34–36] and also as photoinitiators [37]. Furthermore, these derivatives have the applications in material science like semiconductors [38] and in spectroscopy as luminescent agent [39].

Due to the broad utility of acridines, there has been intense demand for the development of new and efficient synthetic protocols for the preparation of these important class of molecules have attracted a large number of organic chemists. Recently, many methods have reported in the literature for the synthesis of acridine derivatives containing 1,4-dihydropyridines, involves the three-component cyclocondensation reaction of 5,5-dimethyl-1,3-cyclohexanedione (dimedone), aromatic aldehydes and various aniline or ammonium acetate in the presence of a several catalysts such as Amberlyst-15 [40], sulfonic acid functionalized silica (SBSSA) [41], ammonium chloride, Proline [12], Zn(OAc)2·H2O or l-proline [42], triethylbenzylammoniumchloride(TEBAC) [43], ZnO nanoparticles [44], nano-Fe3O4 [45], CeCl3·7H2O [46], silica-bonded N-propyl sulfamic acid (SBNPSA) [47]. ionic liquids [48, 49] such as 1-methyl imidazolium trifluoroacetate ([Hmim]TFA) [50] and Bronsted acidic imidazolium salts containing perfluoroalkyl tails [51], microwave irradiation [52, 53], p-dodecylbenzenesulfonicacid (DBSA) [54] and PMA-SiO2 [55].

However, some of these reported methods for the synthesis of 1,8-dioxodecahydroacridine have limitations such as low yields, unpleasant experimental procedure, reagents are expensive or the use of an excess of catalyst, generation of polluting effluents and prolonged reaction times. Therefore, there is scope for further innovation of methods with milder reaction conditions, short reaction times, increase in variation of the substituents in the components and better yields for the synthesis of 1,8-dioxodecahydroacridine, the discovery of new methodologies using new and efficient catalyst is highly desirable.

In continuation to our effort in developing novel transition metal complexes with amino acids for various organic transformations [56–58], herein we would like to report an efficient method for the synthesis of 1,8-dioxodecahydroacridine derivatives through one-pot three component cyclisation reaction catalyzed by cobalt–alanine complex under an aqueous ethanol solvent system.

Results and discussions

Initially, we studied the one-pot three component condensation reaction of benzaldehyde (1 mmol), dimedone (2 mmol) and aniline (1 mmol) as a model reaction in the presence of cobalt–alanine complex (5 mol%) as a catalyst in aqueous ethanol solvent system and the product was obtained in excellent yield (Scheme 1).

Scheme 1.

Scheme 1

Open in a new tab

Synthesis of 1,8-dioxodecahydroacridines 4a catalyzed by cobalt–alanine complex

After successful of the model reaction, we studied for the optimization of the reaction conditions with respect to temperature, time, solvent and molar ratio of the catalyst. It was observed that 5 mol% of catalyst was enough to complete the reaction and the desired 1,8-dioxodecahydroacridines products were obtained in high yield. The results are summarized in Table 1.

Table 1.

Screening the amount of catalyst for the preparation of 1,8-dioxodecahydroacridines

Entry Catalyst (mol%) Time (h) Yield (%)a
1 2.5 4.5 72
2 5 1.0 96
3 10 3.0 90
4 15 3.5 80
Open in a new tab

aYields of isolated products

Further, we performed a screening of various solvents such as acetonitrile, DCM, DMF, EtOH and without solvent system for this reaction (Table 2, entries 1–5). we found ethanol (Table 2, entry 4) was the best solvent to afford the desired products in higher yield in shorter reaction time.

Table 2.

Study of solvent system for the preparation of 1,8-dioxodecahydroacridines

Entry Solvent Time (h) Yield (%)a
1 CH3CN 4.5 72
2 DCM 3.0 80
3 DMF 3.0 90
4 Ethanol 1.0 96
5 Solvent free 4.5 60
Open in a new tab

aYields of isolated products

To evaluate the scope and the generality of this new protocol for various aldehydes and amines under optimized conditions. A series of aromatic aldehydes bearing either electron-donating or electron-withdrawing substituents reacted successfully with dimedone and aromatic amines or ammonium acetate to afford a wide range of substituted 1,8-dioxodecahydroacridines products in high yields in a shorter reaction time and the results are summarized in Table 3. We explored further the electronic effect of various substituents present on the aldehyde component. We noticed that a wide range of aldehydes having both electron-donating and electron-withdrawing substituents are equally facile for the reaction, and gave the corresponding 1,8-dioxodecahydroacridine derivatives in very good yields. We have observed most of the electron-donating aldehydes reacted in a shorter reaction time and gave the corresponding 1,8-dioxodecahydroacridine derivatives in good yields than electron-withdrawing aldehydes.

Table 3.

Synthesis of 1,8-dioxodecahydroacridines catalyzed by cobalt–alanine metal complex under aqueous ethanol medium

Entry Aldehyde (R) R1 or NH4OAC Product Time (h) Yield (%)a Mp. (°C)
1 H Ph 4a 1.0 96 252–254
2 4-OCH3 Ph 4b 1.5 90 220–222
3 4-CH3 Ph 4c 2.0 90 259–262
4 4-CN Ph 4d 2.0 80 267–269
5 4-NO2 Ph 4e 2.5 85 265–267
6 4-OH Ph 4f 2.0 88 232–233
7 4-Cl Ph 4g 2.0 80 244–246
8 4-Br Ph 4h 2.0 85 251–253
9 2-Cl Ph 4i 2.5 75 249–252
10 2-NO2 Ph 4j 3.0 80 272–275
11 3-NO2 Ph 4k 3.0 80 293–295
12 4-OCH3 NH4OAC 4l 2.0 85 272–275
13 4-CH3 NH4OAC 4m 2.0 85 268–271
14 4-CN NH4OAC 4n 2.5 80 281–283
15 4-NO2 NH4OAC 4o 3.0 80 285–287
16 2,3-(Cl)2 Ph 4p 3.0 85 273–276
17 2,3-(OCH3)2 Ph 4q 2.5 95 288–291
18 3,4-(NO2)2 Ph 4r 3.5 80 278–281
19 3,4-(NO2)2 NH4OAC 4s 4.0 75 281–283
20 2,3-(Cl)2 NH4OAC 4t 3.5 80 322–325
21 2,3-(OCH3)2 NH4OAC 4u 3.0 90 303–305
22 2-OH Ph 4v 3.0 85 246–249
Open in a new tab

aYields of isolated products

The physical and spectral data of synthesized compounds were (4a–4v) found to be in agreement with the reported data.

A plausible mechanism for the formation of the 1,8-dioxodecahydroacridine products using cobalt–alanine metal complex as a catalyst has presented in Scheme 2.

Scheme 2.

Scheme 2

Open in a new tab

Plausible mechanism for the formation of the 1,8-dioxodecahydroacridines catalyzed by cobalt–alanine metal complex

We propose that the cobalt–alanine metal complex induces the polarization of the carbonyl groups, of aldehyde (1) and 1,3-diketone (2). Further, we assume that cobalt–alanine metal complex triggers the 1,3-diketone (2) and facilitates the formation of corresponding imine through a condensation reaction with amine 3. The obtained imine, further undergoes tautomerizes to form enamine. Therefore, cobalt–alanine metal complex facilitates the formation of two reactive intermediate species I and II which subsequently react each other via Michael addition and forms the adduct, which further tautomerize. The tautomerized Michael adduct undergoes simple intramolecular ring closure and give the final desired products 4a–4v by loss of water molecule.

Spectral data for selected compounds

3,3,6,6-Tetramethyl-9,10-diphenyl-3,4,6,7-tetrahydroacridine-1,8(2H,5H,9H,10H)-dione (4a)

IR (KBr disc) cm−1: 3120, 2984, 2848, 1664, 1583, 1467, 1437, 1385, 1312, 1244, 1184, 1065, 860, 787, 714, 684. 1H NMR (500 MHz CDCl3): δ 0.86 (s, 6H, 2CH3), 0.94 (s, 6H, 2CH3), 2.14 (d, 2H, J = 16.4 Hz,), 2.23 (d, 2H, J = 16.4 Hz,), 2.24–2.41 (m, 4H, 2CH2), 5.52 (s, 1H), 7.01 (s, 1H, ArH), 7.04 (d, J = 6.2 Hz, 2H, ArH), 7.12–7.28 (m, 5H, ArH), 7.34 (d, J = 6.2 Hz, 2H, ArH). 13C NMR (125 MHz, CDCl3): δ 22.8, 23.4, 36.2, 42.2, 52.4, 123.8, 124.8, 126.6, 127.2, 128.2, 130.6, 132.2, 136.2, 145.8, 151.6, 212.8.

3,3,6,6-Tetramethyl-9-(4-methoxyphenyl)-10-phenyl-3,4,6,7-tetrahydroacridine-1,8(2H,5H,9H,10H)-dione (4b)

IR (KBr disc) cm−1: 3118, 2964, 2902, 2882, 1654, 1614, 1604, 1572, 1502, 1484, 1342, 1274, 1228, 1168, 1058, 856, 734, 658. 1H NMR (500 MHz, CDCl3): 0.83 (s, 6H, 2CH3), 1.02 (s, 6H, 2CH3), 1.24 (d, 2H, J = 14.6 Hz,), 2.14 (d, 2H, J = 14.6 Hz,), 2.25–244 (m, 4H, 2CH2), 3.94 (s, 3H, OCH3), 5.29 (s, 1H), 6.64 (s, 1H, ArH), 6.98 (d, J = 7.6 Hz, 2H, ArH), 7.14–7.28 (m, 3H, ArH), 7.39 (d, J = 7.4 Hz, 2H, ArH). 13C NMR (125 MHz, CDCl3): δ 22.3, 23.8, 35.2, 42.4, 52.5, 125.2, 126.8, 127.5, 129.2, 131.5, 134.2, 136.9, 146.8, 148.3, 150.3, 166.2, 212.6.

3,3,6,6-Tetramethyl-9-(4-cyanophenyl)-10-phenyl-3,4,6,7-tetrahydroacridine-1,8(2H,5H,9H,10H)-dione (4d)

IR (KBr disc) cm−1: 2984, 2912, 2284, 1672, 1548, 1484, 1322, 1277, 1231, 1164, 1123, 1112, 1052, 842, 722, 580. 1H–NMR (500 MHz, CDCl3): δ 0.72 (s, 6H, 2CH3), 0.92 (s, 6H, 2CH3), 1.62 (d, J = 14.5 Hz, 2H, CH2), 2.06 (d, J = 14.5 Hz, 2H, CH2), 2.11 (d, J = 12.2 Hz, 2H, CH2), 2.24 (d, J = 12.2 Hz, 2H, CH2), 5.28 (s, 1H), 7.22 (d, J = 6.0 Hz, 2H, ArH), 7.48 (d, J = 6.4 Hz, 2H, ArH), 7.52 (d, J = 6.0 Hz, 2H, ArH), 7.64 (m, 3H, ArH). 13C-NMR (125 MHz, CDCl3): δ 24.2, 29.8, 30.8, 32.2, 42.4, 52.4, 111.2, 113.8, 121.4, 127.6, 130.7, 132.7, 137.6, 150.2, 154.1, 195.2.

3,3,6,6-Tetramethyl-9-(4-nitrophenyl)-10-phenyl-3,4,6,7-tetrahydroacridine-1,8(2H,5H,9H,10H)-dione (4e)

IR (KBr disc) cm−1: 2982, 1654, 1568, 1544, 1368, 1258, 1146, 1122, 1102, 1068, 882, 856, 724, 588, 526. 1H-NMR (500 MHz, CDCl3): δ 0.74 (s, 6H, 2CH3), 0.92 (s, 6H, 2CH3), 1.35 (d, J = 14.8 Hz, 2H, CH2), 2.08 (d, J = 14.8 Hz, 2H, CH2), 2.12 (d, J = 12.4 Hz, 2H, CH2), 2.18 (d, J = 12.4 Hz, 2H, CH2), 5.16 (s, 1H, CH), 7.14 (d, J = 7.2 Hz, 2H, ArH), 7.58 (d, J = 7.2 Hz, 2H, ArH), 7.62 (s, 1H, ArH), 7.68 (d, J = 8.2 Hz, 2H, ArH), 8.16 (d, J = 8.2 Hz, 2H, ArH). 13C-NMR (125 MHz, CDCl3): δ 24.2, 28.2, 31.6, 36.2, 42.4, 52.3, 113.2, 123.8, 129.2, 130.2, 136.4, 147.8, 151.4, 155.8, 195.8.

3,3,6,6-Tetramethyl-9-(4-hydroxyphenyl)-10-phenyl-3,4,6,7-tetrahydroacridine-1,8(2H,5H,9H,10H)-dione (4f)

IR (KBr disc) cm−1: 3418, 2976, 2912, 2882, 1658, 1584, 1512, 1488, 1433, 1367, 1242, 1184, 1054, 822, 728, 712, 686. 1H NMR (500 MHz, CDCl3): δ 0.82 (s, 6H, 2CH3), 0.92 (s, 6H, 2CH3), 1.48 (d, J = 15.4 Hz, 2H), 2.02 (d, J = 15.4, 2H), 2.28–248 (m, 4H, 2CH2), 5.48 (s, 1H), 7.12 (d, J = 6.8 Hz, 2H, ArH), 7.18–7.23 (m, 4H, ArH), 7.36 (d, J = 6.4 Hz 2H, ArH), 9.11 (s, 1H, OH). 13C NMR (125 MHz, CDCl3): δ 22.8, 23.6, 33.2, 41.2, 55.2, 123.2, 127.8, 129.2, 131.9, 136.2, 138.9, 148.4, 152.7, 153.5, 165.2, 212.6.

3,3,6,6-Tetramethyl-9-(4-chlorophenyl)-10-phenyl-3,4,6,7-tetrahydroacridine-1,8(2H,5H,9H,10H)-dione (4g)

1H-NMR (500 MHz, CDCl3): δ 0.78 (s, 6H, 2CH3), 0.82 (s, 6H, 2CH3), 1.69 (d, J = 16.6 Hz, 2H, CH2), 2. 21 (d, J = 16.6 Hz, 2H, CH2), 2.08 (d, J = 14.8 Hz, 2H, CH2), 2.14 (d, J = 14.8 Hz, 2H, CH2), 5.21 (s, 1H, CH), 7.14 (d, J = 7.6 Hz, 2H, ArH), 7.21 (d, J = 7.6 Hz, 2H, ArH), 7.38 (d, J = 8.6 Hz, 2H, ArH), 7.44 (m, 3H, ArH).

3,3,6,6-Tetramethyl-9-(4-bromophenyl)-10-phenyl-3,4,6,7-tetrahydroacridine-1,8(2H,5H,9H,10H)-dione (4h)

IR (KBr disc) cm−1: 3024, 2986, 2848, 1665, 1642, 1564, 1474, 1432, 1422, 1402, 1384, 1342, 1248, 1218, 1184, 1136, 1054, 1038, 1024, 936, 875, 741, 712, 684. 1H NMR (500 MHz, CDCl3): δ 0.74 (s, 6H, 2CH3), 0.86 (s, 6H, 2CH3), 1.72 (d, J = 16.8 Hz, 2H, 2CH), 2.18 (d, J = 16.8 Hz, 2H, 2CH), 2.21–2.28 (m, 4H, 2CH2), 5.18 (s, 1 H, CH), 7.26 (d, J = 6.8 Hz, 2H, ArH), 7.42–7.48 (m, 4H, ArH), 7.62–7.66 (m, 3H, ArH). 13C NMR (125 MHz, CDCl3): δ 24.6, 28.2, 31.8, 33.6, 43.5, 51.2, 113.2, 117.7, 128.2, 129.8, 130.6, 132.6, 139.1, 145.2, 151.2, 196.8.

3,3,6,6-Tetramethyl-9-(3-nitrophenyl)-10-phenyl-3,4,6,7-tetrahydroacridine-1,8(2H,5H,9H,10H)-dione (4k)

1H-NMR (500 MHz, CDCl3): δ 0.82 (s, 6H, 2CH3), 0.94 (s, 6H, 2CH3), 1.78 (d, J = 16.6 Hz, 2H, CH2), 2.08 (d, J = 16.4 Hz, 2H, CH2), 2.16 (d, J = 13.6 Hz, 2H, CH2), 2.28 (d, J = 13.6 Hz, 2H, CH2), 5.42 (s, 1H, CH), 7.34 (m, 1H, ArH), 7.46 (m, 2H, ArH), 7.64 (m, 3H, ArH), 7.94 (m, 2H, ArH), 8.38 (s, 1H, ArH).

3,3,6,6-Tetramethyl-9-(4-methoxyphenyl)-3,4,6,7-tetrahydroacridine-1,8(2H,5H,9H,10H)-dione (4l)

IR (KBr disc) cm−1: 3184, 1648, 1617, 1462, 1366, 1223, 1138, 1084, 968, 748, 646. 1H NMR (500 MHz, CDCl3): δ 0.94 (s, 6H, 2 CH3), 1.05 (s, 6H, 2CH3), 2.09–2.16 (dd, 4H), 2.19–2.28 (m, 4H, 2 CH2), 3.66 (s, 3H), 5.04 (s, 1H), 6.69–6.73 (d, J = 8.4 Hz, 2H, ArH), 7.23–7.26 (d, J = 7.6 Hz, 2H, ArH), 8.22 (s, 1H, NH).

3,3,6,6-Tetramethyl-9-(4-nitrophenyl)-3,4,6,7-tetrahydroacridine-1,8(2H,5H,9H,10H)-dione (4o)

1H-NMR (500 MHz, CDCl3) δ 0.98 (s, 6H, 2CH3), 1.08 (s, 6H, 2CH3), 2.14 (d, J = 16.5 Hz, 2H), 2.34 (d, J = 16.2 Hz, 2H), 2.38 (d, J = 14.8 Hz, 2H), 2.52 (d, J = 14.8 Hz, 2H), 5.24 (s, 1H, CH), 6.18 (s br., 1H, NH), 7.68 (d, J = 7.8 Hz, 2H, arom-H), 8.16 (d, J = 7.8 Hz, 2H, arom-H).

3,3,6,6-Tetramethyl-9-(2,3-dichlorophenyl)-10-phenyl-3,4,6,7-tetrahydroacridine-1,8(2H,5H,9H,10H)-dione (4p)

IR (KBr disc) cm−1: 2954, 2936, 1658, 1642, 1585, 1464, 1342, 1268, 1176, 1049, 1024, 842, 738, 582. 1H-NMR (500 MHz, CDCl3): δ 0.84 (s, 6H, 2CH3), 0.98 (s, 6H, 2CH3), 1.76 (d, J = 17.6 Hz, 2H, CH2), 2.16 (d, J = 17.6 Hz, 2H, CH2), 2.34 (m, 4H, CH2), 5.28 (s, 1H, CH), 7.24 (m, 2H, ArH), 7.38 (m, 2H, ArH), 7.48 (s 1H, ArH), 7.52 (m, 3H, ArH). 13C-NMR (125 MHz, CDCl3): δ 26.2, 30.4, 31.6, 43.2, 51.8, 113.2, 126.8, 129.2, 130.2, 131.3, 133.2, 136.5, 145.2, 151.7, 196.2.

3,3,6,6-Tetramethyl-9-(2,3-dimethoxyphenyl)-10-phenyl-3,4,6,7-tetrahydroacridine-1,8(2H,5H,9H,10H)-dione (4q)

IR (KBr disc) cm−1: 3412, 1654, 1454, 1382, 1231, 1130, 1065, 978, 768, 645. 1H NMR (500 MHz, CDCl3): δ 0.88 (s, 6H, 2CH3), 0.94 (s, 6H, 2CH3), 1.86–2.24 (dd, 4H), 2.32–2.46 (dd, 4H), 3.84 (s, 3H, OCH3), 3.94 (s, 3H, OCH3), 5.12 (s, 1H), 6.72–6.84 (m, 3H, ArH), 9.12 (s, 1H, NH).

Conclusion

In conclusion, we have developed a facile and an efficient protocol for the synthesis of 1,8-dioxodecahydroacridines using cobalt–alanine metal complex as a catalyst in aqueous ethanol as solvent via one-pot three-component condensation of aromatic aldehydes, dimedone, aniline or ammonium acetate. Significant advantages of this study are reasonably simple experimental workup procedure and catalyst preparation, ease of product isolation, high to excellent yields, short reaction time and using catalytic amount of cobalt–alanine metal complex, are notable advantages of the present methodology.

Experimental procedure

Materials and methods

All chemicals were purchased from Sigma Aldrich and used as received without further purification. All chemicals and reagents used in the present study were of analytical grade. The reactions were monitored by TLC using silicagel plates. The FTIR spectra were recorded on a Shimadzu JASCO FTIR-460 plus spectrometer using KBr pellets or neat. The UV–visible spectra of the compounds were recorded on Shimadzu UV-2100 spectrophotometer. The morphology of synthesized complex was characterized by Scanning electron microscopy (SEM) on a JEOL-JSM-6390 LV. 1H NMR and 13C NMR spectra were recorded on a Brucker DRX 500 AVANCE (500 MHz) spectrometer using CDCl3 as solvent and TMS as internal standard. The elemental analysis of the complexes were recorded by using Perkin-Elmer CHN-2400 analyzer their results were found to be good agreement with the calculated values. Photoluminance spectra of the complexes and ligands were recorded on LUMINA fluorescence spectrometer of Thermo Scientific Co. USA. The XRD measurements were performed on Schimadzu DX-6000 using Cu for Kα-particle source.

General procedure for the preparation of cobalt–alanine complex

It is commonly well-known that a metal ion can bind two amino acids to form an amino acid metal complex (Fig. 1). Therefore, amino acid-metal complexes were prepared in hot ethanol solvent by reacting the corresponding metal ion and amino acid in a 1:2 molar ratio.

Fig. 1.

Fig. 1

Open in a new tab

Probable structure for Co–alanine metal complex

The synthesis of cobalt–alanine metal complex was achieved in a two steps. In a first step, the CoCl2·6H2O (2.4 g) metal salt was dissolved in a hot ethanol solvent and l-alanine (1.8 g) amino acid ligand also dissolved in ethanol separately. In the second step, the resultant solution of ligand was slowly added drop by drop into the metal salt solution under vigorous stirring. Once the addition of ligand solution was completed, then 0.01 M Na2CO3 solution also added slowly to adjust the PH around 6.5 to 8.5 for the formation of Co–alanine metal complex. The reaction mixture was refluxed for 3 h at 80 °C under vigorous stirring (Scheme 3) [56–58]. The reaction progress was observed by TLC. The mobile phase condition was n-butanol:acetone:acetic acid:water (7:7:2:4) used as a solvent system. The TLC plate was run in this solvent system and the obtained amino acid metal complex was moved well on the TLC plate and also visualized by using solution of ninhydrin. After completion of the reaction, as indicated by TLC, the mixture was allowed to cooled at room temperature; thus the obtained solid crude product was separated by filtration and the crude product was recrystallized in acetone and diethyl ether solvent system with constant stirring under reflux for a period of time, later it was allowed to cool. The resultant solid product was filtered and dried under vacuum. The obtained pure solid product was in a purple color.

Scheme 3.

Scheme 3

Open in a new tab

Synthesis of cobalt–alanine metal complex

IR (KBr, ν cm−1): 3084 (νOH), 1620 (νC=N), 1014 (νCo–O), 485 (νCo–N).

Elemental analysis: C: 30.14%, H: 5.52%, N: 11.82%, Co: 25.24%.

The synthesized cobalt–alanine metal complex was characterized by using photoluminescence spectroscopy, which provided an evidence of complexation. The recorded emission spectra showed an interesting evidence for the complex formation. The emissions at λmax 556–566 and 660–730 nm provide evidence that the metal atoms are transferring energy to the ligand (alanine) hence; promoting the photoluminescence to the organic ligand (Fig. 2).

Fig. 2.

Fig. 2

Open in a new tab

Photoluminence (PL) emission spectra for Co–alanine metal complex

Further evidence to suggest this justification was revealed by the powder XRD analysis of the complex. The obtained new peaks were observed at 30–40 θ which clearly provides the evidence for the formation of complex (Fig. 3).

Fig. 3.

Fig. 3

Open in a new tab

The XRD of cobalt–alanine metal complex

The final evidence of complex composition was predicted from by SEM analysis. The SEM-micrograph for the cobalt–alanine has shown in Fig. 4. The morphology, texture and shape of the synthesized complex with varying thickness in the range of 5 to 10 µm are seen. The morphology of this complex was seen as rods at different magnifications.

Fig. 4.

Fig. 4

Open in a new tab

SEM micrograph of Co–alanine complex; at different magnifications showing the structure of rods

General procedure for the synthesis of 1,8-dioxodecahydroacridines catalyzed by cobalt–alanine metal complex

A mixture of an aromatic aldehyde 1 (1 mmol), 5,5-dimethyl-1,3-cyclohexanedione 2 (2 mmol), aromatic amine or ammonium acetate 3 (1.2 mmol) and cobalt–alanine complex (5 mol%) in ethanol (10 mL) was stirred at reflux. The progress of the reaction was monitored by TLC. After completion of the reaction as indicated by TLC, the mixture was cooled to room temperature and filtered. The filtrate was concentrated to obtained the crude product. The crude products were purified and recrystallized from EtOH and water mixture to obtain pure products in high yields (Scheme 4).

Scheme 4.

Scheme 4

Open in a new tab

Synthesis of 1,8-dioxodecahydroacridines 4a–v catalyzed by cobalt–alanine complex

Authors’ contributions

MMA, ATM, MAA, SMA and AMF designed and performed the research. MMA, SMA and AMF did the sample collection. MMA, ATM, MAA and SMA analyzed the data and interpreted the results. MMA, MAA and AMF wrote the manuscript. All authors read and approved the final manuscript.

Acknowledgements

The authors are thankful to Dean of Scientific Research, King Khalid University and the College of Science. Department of Chemistry for providing facilities to carry out our research work.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

The datasets generated and analysed during the current study available from the corresponding author on reasonable request.

Funding

This work was supported by the Dean of Scientific Research, King Khalid University for the financial support is greatly appreciated for the General Research Project under grant number [G. P. R. 193/38].

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abbreviations

MCR

multi-component reactions

DHPs

1,4-dihydropyridines

SBSSA

sulfonic acid functionalized silica

TEBAC

triethylbenzylammoniumchloride

SBNPSA

silica-bonded N-propyl sulfamic acid

[Hmim]TFA

1-methyl imidazolium trifluoroacetate

DBSA

p-dodecylbenzenesulfonicacid

DCM

dichloromethane

DMF

dimethylformamide

EtOH

ethanol

SEM

scanning electron microscope

FT-IR

Fourier transform infrared spectroscopy

TLC

thin layer chromatography

Contributor Information

M. Mujahid Alam, Phone: 00966-17-2418225, Phone: 00966-531584630, Email: malm@kku.edu.sa, Email: mmujahidalam@gmail.com.

Ahmed T. Mubarak, Email: atmubarak@kku.edu.sa

Mohammed A. Assiri, Email: maassiri@kku.edu.sa

S. Merajuddin Ahmed, Email: sm_ahmed@hotmail.com.

Ahmed M. Fouda, Email: amfodeh@kku.edu.sa

References

  • 1.Negwar M. In organic-chemical drugs and their synonyms. Berlin: Akademie; 1994. [Google Scholar]
  • 2.Dekamin MG, Mokhtari Z, Karimi Z. Nano-ordered B-MCM-41: an efficient and recoverable solid acid catalyst for three-component Strecker reaction of carbonyl catalyst for three-component Strecker reaction of carbonyl. Sci Iran Trans C. 2011;18:1356–1364. doi: 10.1016/j.scient.2011.11.005. [DOI] [Google Scholar]
  • 3.Gerencser J, Dormon G, Darvas F. Meldrum’s acid in multicomponent reaction: applications to combinatorial and diversity-oriented synthesis. QSAR Comb Sci. 2006;25:439–448. doi: 10.1002/qsar.200540212. [DOI] [Google Scholar]
  • 4.Ramon DJ, Yus M. Asymmetric multicomponent reactions (AMCRs): the new frontier. Angew Chem Int Ed. 2005;44:1602–1634. doi: 10.1002/anie.200460548. [DOI] [PubMed] [Google Scholar]
  • 5.Domling A, Ugi I. Multicomponent reactions with isocyanides. Angew Chem Int Ed. 2000;39:3168–3210. doi: 10.1002/1521-3773(20000915)39:18<3168::AID-ANIE3168>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
  • 6.Strubing D, Neumann H, Klaus S, Hubner S, Beller M. A facile and efficient synthesis of enyne-reaction precursors by multicomponent reactions. Tetrahedron. 2005;61:11333–11344. doi: 10.1016/j.tet.2005.09.097. [DOI] [Google Scholar]
  • 7.Heydari A, Arefi A, Khaksar S, Shiroodi RK. Guanidine hydrochloride: an active and simple catalyst for Strecker type reaction. J Mol Catal A. 2007;271:142–144. doi: 10.1016/j.molcata.2007.02.046. [DOI] [Google Scholar]
  • 8.Guillena G, Ramon DJ, Yus M. Organocatalytic enantioselective multicomponent reactions (OEMCRs) Tetrahedron Asymmetry. 2007;18:693–700. doi: 10.1016/j.tetasy.2007.03.002. [DOI] [Google Scholar]
  • 9.Yu L, Chen B, Huang X. Multicomponent reactions of allenes, diaryl diselenides, and nucleophiles in the presence of iodosobenzene diacetate: direct synthesis of 3-functionalized-2-arylselenyl substituted allyl derivatives. Tetrahedron Lett. 2007;48:925–927. doi: 10.1016/j.tetlet.2006.12.026. [DOI] [Google Scholar]
  • 10.Lee D, Sello JK, Schreiber SL. Pairwise use of complexity-generating reactions in diversity-oriented organic synthesis. Org Lett. 2000;2:709–712. doi: 10.1021/ol005574n. [DOI] [PubMed] [Google Scholar]
  • 11.Zhu J. Recent developments in the isonitrile-based multicomponent synthesis of heterocycles. Eur J Org Chem. 2003;7:1133–1144. doi: 10.1002/ejoc.200390167. [DOI] [Google Scholar]
  • 12.Venkatesan K, Pujari SS, Srinivasan KV. Proline-catalyzed simple and efficient synthesis of 1,8-dioxodecahydroacridines in aqueous ethanol medium. Synth Commun. 2009;39:228–244. doi: 10.1080/00397910802044306. [DOI] [Google Scholar]
  • 13.Mikata Y, Yokoyama M, Mogami K, Kato M, Okura I, Chikira M, Yano S. Intercalator-linked cisplatin: synthesis and antitumor activity of cis-dichloroplatinum (II) complexes connected to acridine and phenylquinolines by one ethylene chain. Inorg Chim Acta. 1998;279:51–57. doi: 10.1016/S0020-1693(98)00035-8. [DOI] [Google Scholar]
  • 14.Sirisha K, Bikshapathi D, Achaiah G, Reddy VM. Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines. Eur J Med Chem. 2011;46:1564–1571. doi: 10.1016/j.ejmech.2011.02.003. [DOI] [PubMed] [Google Scholar]
  • 15.Spalding DP, Chapin EC, Mosher HS. Heterocyclic basic compounds. XV. Benzacridine derivatives. J Org Chem. 1954;19:357–364. doi: 10.1021/jo01368a011. [DOI] [Google Scholar]
  • 16.Solanki MJ, Vachharajani PR, Dubal GG, Shah VH. Synthesis and antimicrobial evaluation of some newer symmetrical 1,4-dihydropyridines. Int J ChemTech Res. 2011;3:1139–1144. [Google Scholar]
  • 17.Ogawa T, Nakato A, Tsuchida K, Hatayama K. Synthesis and antihypertensive activities of new 1,4-dihydropyridine derivatives containing a nitrooxy moiety at the 3-ester position. Chem Pharm Bull. 1993;41:108–116. doi: 10.1248/cpb.41.108. [DOI] [PubMed] [Google Scholar]
  • 18.Wainwright M. Acridine—a neglected antibacterial chromophore. J Antimicrob Chemother. 2001;47:1–13. doi: 10.1093/jac/47.1.1. [DOI] [PubMed] [Google Scholar]
  • 19.Sirisha K, Achaiah G, Reddy VM. Facile synthesis and antibacterial, antitubercular, and anticancer activities of novel 1,4-dihydropyridines. Arch Pharm. 2010;343:342–352. doi: 10.1002/ardp.200900243. [DOI] [PubMed] [Google Scholar]
  • 20.Jain SM, Kant R, Devi S, Dahr KL, Singh S, Bani S, Singh GB. Indian J Chem Sect B. 1990;29:95. [Google Scholar]
  • 21.Godfraid T, Miller R, Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol Rev. 1986;38:321–416. [PubMed] [Google Scholar]
  • 22.Bossert F, Vater W. 1,4-Dihydropyridines—a basis for developing new drugs. Med Res Rev. 1989;9:291–324. doi: 10.1002/med.2610090304. [DOI] [PubMed] [Google Scholar]
  • 23.Berkan O, Sarac B, Simsek R, Yildirim S, Sariogli Y, Safak C. Vasorelaxing properties of some phenylacridine type potassium channel openers in isolated rabbit thoracic arteries. Eur J Med Chem. 2002;37:519–523. doi: 10.1016/S0223-5234(02)01374-0. [DOI] [PubMed] [Google Scholar]
  • 24.Stou DM, Meyers AI. Recent advances in the chemistry of dihydropyridines. Chem Rev. 1982;82:223–243. doi: 10.1021/cr00048a004. [DOI] [Google Scholar]
  • 25.Antman E, Muller J, Goldberg S, Macalpin R, Rubenfire M, Tabatznik B, Liang C, Heupler F, Achuff S, Reichek N, Geltman E, Kerin NZ, Neff RK, Raunwald E. Nifedipine therapy for coronary–artery spasm—experience in 127 patients. N Engl J Med. 1980;302:1269–1273. doi: 10.1056/NEJM198006053022301. [DOI] [PubMed] [Google Scholar]
  • 26.Guazzi M, Olivari M, Polese A, Fiorentini C, Margrini F, Moruzzi P. Nifedipine, a new antihypertensive with rapid action. Clin Pharmacol Ther. 1977;22:528–532. doi: 10.1002/cpt1977225part1528. [DOI] [PubMed] [Google Scholar]
  • 27.Hornung RS, Gould BA, Jones RI, Sonecha TN, Raferty EB. Nifedipine tablets for systemic hypertension: a study using continuous ambulatory intraarterial recording. Am J Cardiol. 1983;51:1323–1325. doi: 10.1016/0002-9149(83)90306-5. [DOI] [PubMed] [Google Scholar]
  • 28.Bossert F, Meyer H, Wehinger E. 4-Aryldihydropyridines, a new class of highly active calcium antagonists. Angew Chem Int Ed Engl. 1981;20:762–769. doi: 10.1002/anie.198107621. [DOI] [Google Scholar]
  • 29.Bretzel RG, Bollen CC, Maeser E, Federlin KF. Drugs Future. 1992;17:465. doi: 10.1358/dof.1992.017.06.175816. [DOI] [Google Scholar]
  • 30.Vo D, Matowe WC, Ramesh M, Iqbal N, Wolowyk MW, Howlett SE, Knaus E. Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enantiomers. J Med Chem. 1995;38:2851–2859. doi: 10.1021/jm00015a007. [DOI] [PubMed] [Google Scholar]
  • 31.Delfourne E, Roubin C, Bastide J. The first synthesis of the pentacyclic pyridoacridine marine alkaloids: arnoamines A and B. J Org Chem. 2000;65:5476–5479. doi: 10.1021/jo000011a. [DOI] [PubMed] [Google Scholar]
  • 32.Ferlin MG, Marzano C, Chiarelotto G, Bordin F, Baccichetti F. Synthesis and antiproliferative activity of some variously substituted acridineand azacridine derivatives. Eur J Med Chem. 2000;35:827–837. doi: 10.1016/S0223-5234(00)00170-7. [DOI] [PubMed] [Google Scholar]
  • 33.Gordeev MF, Patel DV, Gordon EM. Approaches to combinatorial synthesis of heterocycles: a solid-phase synthesis of 1,4-dihydropyridines. J Org Chem. 1996;61:924–928. doi: 10.1021/jo951706s. [DOI] [Google Scholar]
  • 34.Shanmugasundaram P, Murugan P, Ramakrishnan VT. Synthesis of acridinedione derivatives as laser dyes. Heteroat Chem. 1996;7:17–22. doi: 10.1002/(SICI)1098-1071(199601)7:1<17::AID-HC3>3.0.CO;2-#. [DOI] [Google Scholar]
  • 35.Murugan P, Shanmugasundaram P, Ramakrishnan VT, Venkatachalapathy B, Srividya N, Ramamurthy P, Gunasekaran K, Velmurugan D. Synthesis and laser properties of 9-alkyl-3,3,6,6-tetramethyl-1,2,3,4,5,6,7,8,9,10-decahydroacridine-1,8-dione derivatives. J Chem Soc Perkin Trans. 1998;2:999–1004. doi: 10.1039/a701401e. [DOI] [Google Scholar]
  • 36.Islam A, Murugan P, Hwang KC, Cheng CH. Blue lightemitting devices based on 1,8-acridinedione derivatives. Synth Met. 2003;139:347–353. doi: 10.1016/S0379-6779(03)00188-7. [DOI] [Google Scholar]
  • 37.Tu SJ, Miao C, Gao Y, Fang F, Zhuang Q, Feng Y, Shi D. Novel cascade reaction of aryl aldoxime with dimedone under microwave irradiation: the synthesis of N-hydroxylacridine. Synlett. 2004;2:255–258. doi: 10.1055/s-2003-44981. [DOI] [Google Scholar]
  • 38.Papagni A, Campiglio P, Campione M. Synthesis and physical properties of polyfluoro-acridines bearing perfluoroalkyl chains. J Fluor Chem. 2008;129:294–300. doi: 10.1016/j.jfluchem.2008.01.005. [DOI] [Google Scholar]
  • 39.Reddy BVS, Antony A, Yadav JS. Novel intramolecular aza-Diels–Alder reaction: a facile synthesis of trans-fused 5H-chromeno[2,3-c] acridine derivatives. Tetrahedron Lett. 2010;51:3071–3074. doi: 10.1016/j.tetlet.2010.04.018. [DOI] [Google Scholar]
  • 40.Das B, Thirupathi P, Mahender I, Reddy VS, Rao YK. Amberlyst-15: an efficient reusable heterogeneous catalyst for the synthesis of 1,8-dioxo-octahydroxanthenes and 1,8-dioxo-decahydroacridines. J Mol Catal A. 2006;247:233–239. doi: 10.1016/j.molcata.2005.11.048. [DOI] [Google Scholar]
  • 41.Niknam K, Panahi F, Saberi D, Mohagheghnejad M. Silica-bonded S-sulfonic acid as recyclable catalyst for the synthesis of 1,8-dioxo-decahydroacridines and 1,8-dioxo-octahydroxanthenes. J Heterocycl Chem. 2010;47:292–300. [Google Scholar]
  • 42.Balalaie S, Chadegani F, Darviche F, Bijanzadeh HR. One-pot synthesis of 1,8-dioxo-decahydroacridine derivatives in aqueous media. Chin J Chem. 2009;27:1953–1956. doi: 10.1002/cjoc.200990328. [DOI] [Google Scholar]
  • 43.Wang XS, Shi DQ, Zhang YF, Wang SH, Tu SJ. Chin J Org Chem. 2004;24:430–432. [Google Scholar]
  • 44.Safaei-Ghomi J, Ghasemzadeh MA, Zahedi S. ZnO nanoparticles: a highly effective and readily recyclable catalyst for the one-pot synthesis of 1,8-dioxo-decahydroacridine and 1,8-dioxooctahydro-xanthene derivatives. J Mexi Chem Soc. 2013;57:1–7. [Google Scholar]
  • 45.Ghasemzadeh MA, Safaei-Ghomi J, Molaei H. Fe3O4 nanoparticles: as an efficient, green and magnetically reusable catalyst for the one-pot synthesis of 1, 8-dioxo-decahydroacridine derivatives under solvent-free conditions. C R Chim. 2012;15:969–974. doi: 10.1016/j.crci.2012.08.010. [DOI] [Google Scholar]
  • 46.Fan X, Li Y, Zhang X, Qu G, Wang J. An efficient and green preparation of 9-arylacridine-1,8-dione derivatives. J Heteroat Chem. 2007;18:786–790. doi: 10.1002/hc.20410. [DOI] [Google Scholar]
  • 47.Rashedian F, Saberib D, Niknam K. Silica-bonded N-propyl sulfamic acid: a recyclable catalyst for the synthesis of 1,8-dioxo-decahydroacridines, 1,8-dioxo-octahydroxanthenes and quinoxalines. J Chin Chem Soc. 2010;57:998–1006. doi: 10.1002/jccs.201000139. [DOI] [Google Scholar]
  • 48.Li YL, Zhang MM, Wang XS, Shi DQ, Tu SJ, Wei XY, Zong ZM. J Chem Res. 2005;44:600–605. doi: 10.3184/030823405774308853. [DOI] [Google Scholar]
  • 49.Zhang MM, Wang XS, Jiang H, Shi DQ, Tu SJ, Wei XY, Zong ZM. An improved and benign synthesis of 9,10-diarylacridine-1,8-dione and indenoquinoline derivatives from 3-anilino-5,5-dimethylcyclohex-2-enones, benzaldehydes, and 1,3-dicarbonyl compounds in an ionic liquid medium. Synthesis. 2006;24:4187–4199. [Google Scholar]
  • 50.Dabiri M, Baghbanzadeh M, Arzroomchilar E. 1-Methylimidazolium triflouroacetate ([Hmim]TFA): an efficient reusable acidic ionic liquid for the synthesis of 1,8-dioxo-octahydroxanthenes and 1,8-dioxo-decahydroacridines. Catal Commun. 2008;9:939–942. doi: 10.1016/j.catcom.2007.09.023. [DOI] [Google Scholar]
  • 51.Shen W, Wang LM, Tian H, Tang J, Yu JJ. Brønsted acidic imidazolium salts containing perfluoroalkyl tails catalyzed one-pot synthesis of 1,8-dioxo-decahydroacridines in water. J Fluor Chem. 2009;130:522–527. doi: 10.1016/j.jfluchem.2009.02.014. [DOI] [Google Scholar]
  • 52.Miao CB, Tu SJ, Gao Y, Feng YJ, Feng JC. Microwave-prompted reaction of cinnamonitrile derivatives with 5,5-dimethyl-1,3-cyclohexanedione. Chin J Chem. 2002;20:703–706. [Google Scholar]
  • 53.Wang XS, Shi DQ, Wang SH, Tu SJ. Chin J Org Chem. 2003;23:1291–1293. doi: 10.1016/j.cjche.2015.04.017. [DOI] [Google Scholar]
  • 54.Jin TS, Zhang JS, Guo TT, Wang AQ, Li TS. One-pot clean synthesis of 1,8-dioxo-decahydroacridines catalyzed by p-dodecylbenezenesulfonic acid in aqueous media. Synthesis. 2004;12:2001–2005. doi: 10.1055/s-2004-829151. [DOI] [Google Scholar]
  • 55.Subramanyam M, Varala R, Sreenivasulu R, Rao MVB, Rao KP. A facile, efficient and convenient synthesis of 1,8-dioxodecahydroacridines with PMA-SiO2 reusable catalyst. Lett Org Chem. 2018;15:915–921. doi: 10.2174/1570178615666180212153735. [DOI] [Google Scholar]
  • 56.Merajuddin SA, Mubarak AT, Alam MM, Halima AAA. Cyclohexane oxidation: synthesis and characterization of amino acid metal complexes and their catalytic activity evaluation. Int J Basic Appl Chem Sci. 2013;3:29–40. [Google Scholar]
  • 57.Merajuddin SA, Mubarak AT, Fouda AA, Alam MM, Sabr SA. Cyclohexane oxidation: synthesis of 1,10 phenanthroline Cu (II) complexes by classical, microwave and hydrothermal methods and their catalytic activity evaluation. Int J Basic Appl Chem Sci. 2013;3:69–78. [Google Scholar]
  • 58.Merajuddin SA, Mubarak AT, Alam MM, Halima AAA. Cyclohexane oxidation: synthesis of iron (III)-amino acid and amino acid Schiff base complexes and their catalytic activity evaluation. Am Chem Sci J. 2014;4:600–615. doi: 10.9734/ACSJ/2014/9185. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets generated and analysed during the current study available from the corresponding author on reasonable request.

Articles from BMC Chemistry are provided here courtesy of BMC

RESOURCES